Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion type Assertion NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_head.
- NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion description "[Our studies revealed that expression levels of microRNA-124 and microRNA-137 were significantly decreased in anaplastic astrocytomas (World Health Organization grade III) and glioblastoma multiforme (World Health Organization grade IV) relative to non-neoplastic brain tissue (P < 0.01), and were increased 8- to 20-fold during differentiation of cultured mouse neural stem cells following growth factor withdrawal.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_provenance.
- NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion evidence source_evidence_literature NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_provenance.
- NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion SIO_000772 18577219 NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_provenance.
- NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion wasDerivedFrom befree-20140225 NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_provenance.
- NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_assertion wasGeneratedBy ECO_0000203 NP629827.RARMu2lApNSpygjKrwRjqrODEQOu5tnegu1uL32mFxsUc130_provenance.